Sheng Li

13.2k total citations · 1 hit paper
389 papers, 8.0k citations indexed

About

Sheng Li is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Sheng Li has authored 389 papers receiving a total of 8.0k indexed citations (citations by other indexed papers that have themselves been cited), including 118 papers in Molecular Biology, 89 papers in Pulmonary and Respiratory Medicine and 72 papers in Surgery. Recurrent topics in Sheng Li's work include Cancer-related molecular mechanisms research (30 papers), Ferroptosis and cancer prognosis (24 papers) and MicroRNA in disease regulation (22 papers). Sheng Li is often cited by papers focused on Cancer-related molecular mechanisms research (30 papers), Ferroptosis and cancer prognosis (24 papers) and MicroRNA in disease regulation (22 papers). Sheng Li collaborates with scholars based in China, United States and Germany. Sheng Li's co-authors include Xian‐Tao Zeng, Chao Zhang, Yonggang Zhang, Joey S.W. Kwong, Liang Du, Feng Sun, Yu‐Ming Niu, A. Richard Whorton, Lina Zhang and Xinghuan Wang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Sheng Li

365 papers receiving 7.9k citations

Hit Papers

The methodological qualit... 2015 2026 2018 2022 2015 500 1000 1.5k

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Sheng Li 2.7k 1.2k 1.2k 1.0k 889 389 8.0k
Jingwen Zhang 3.4k 1.3× 1.2k 1.0× 985 0.8× 774 0.7× 1.4k 1.6× 296 7.7k
Hui Li 3.1k 1.1× 1.6k 1.3× 1.1k 0.9× 733 0.7× 816 0.9× 302 7.5k
Yonggang Zhang 2.2k 0.8× 728 0.6× 746 0.6× 1.4k 1.3× 1.4k 1.6× 350 8.5k
Jung Tak Park 2.4k 0.9× 833 0.7× 1.3k 1.1× 1.5k 1.4× 784 0.9× 576 11.0k
Gcf Chan 2.1k 0.8× 573 0.5× 788 0.7× 728 0.7× 1.0k 1.2× 358 8.7k
Lan Huang 3.2k 1.2× 1.4k 1.1× 1.2k 1.0× 956 0.9× 1.6k 1.8× 309 8.7k
Ming‐Tsang Wu 2.2k 0.8× 1.2k 1.0× 1.7k 1.4× 1.4k 1.3× 1.0k 1.2× 394 10.0k
Wei Xiao 2.6k 1.0× 727 0.6× 1.1k 0.9× 587 0.6× 1.1k 1.3× 481 8.0k
Yan Wang 4.8k 1.8× 2.3k 1.9× 718 0.6× 668 0.6× 1.2k 1.4× 512 9.8k
Wen Zhang 4.3k 1.6× 1.8k 1.4× 1.2k 1.0× 1.1k 1.0× 2.1k 2.3× 494 11.0k

Countries citing papers authored by Sheng Li

Since Specialization
Citations

This map shows the geographic impact of Sheng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheng Li more than expected).

Fields of papers citing papers by Sheng Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheng Li. The network helps show where Sheng Li may publish in the future.

Co-authorship network of co-authors of Sheng Li

This figure shows the co-authorship network connecting the top 25 collaborators of Sheng Li. A scholar is included among the top collaborators of Sheng Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheng Li. Sheng Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ran, Hao, Jianmin Huang, Xintong Zhang, et al.. (2025). P0848 Engineering and Development of a Novel Bispecific Antibody Targeting both TL1A and α4β7 for the Treatment of IBD. Journal of Crohn s and Colitis. 19(Supplement_1). i1618–i1618. 1 indexed citations
2.
Lu, Junlin, Hong Li, Tingting Li, et al.. (2025). Resveratrol Induces Oxidative Stress and Downregulates GPX4 and xCT to Activate the Ferroptosis Pathway for Anti-Bladder Cancer Organoids. Journal of Cancer. 16(8). 2613–2625. 2 indexed citations
3.
Yao, Xiangyang, Haoran Liu, Chen Duan, et al.. (2025). Sirtuin1 mitigation of calcium oxalate nephropathy via enhancing itaconate abundance through reduction of histone trimethylation. Clinical and Translational Medicine. 15(8). e70450–e70450.
4.
Li, Sheng, Yao Wang, Qianqian Liu, et al.. (2024). RBC-hitchhiking PLGA nanoparticles loading β-glucan as a delivery system to enhance in vitro and in vivo immune responses in mice. Frontiers in Veterinary Science. 11. 1462518–1462518. 2 indexed citations
5.
Li, Jianqiang, et al.. (2024). Conquer coronary artery perforation with magic hands. Journal of Geriatric Cardiology. 21(4). 379–386.
6.
Li, Donghui, Wenbo Li, Sheng Li, et al.. (2024). Fabrication of chitosan-based emulsion as an adjuvant to enhance nasal mucosal immune responses. International Journal of Biological Macromolecules. 272(Pt 2). 132913–132913. 5 indexed citations
7.
Jiang, Yulin, et al.. (2024). Dissolution and intrusion of chloride disrupted biodegradation products to persistently accelerate biodegradation of Fe-based implants. Corrosion Science. 240. 112461–112461. 8 indexed citations
8.
Jiang, Yulin, et al.. (2024). Accelerated biodegradation of Fe-30Mn-S biocomposite via preferential corrosion of secondary phase. Intermetallics. 175. 108539–108539.
9.
Wang, Yuxin, Manman Shi, Sheng Li, et al.. (2024). Shen-Qi-Di-Huang Decoction induces autophagy in podocytes to ameliorate membranous nephropathy by suppressing USP14. Journal of Ethnopharmacology. 340. 119228–119228. 1 indexed citations
10.
11.
Xiong, Jing, Sheng Li, Xiaoqiang Liu, et al.. (2023). Mitochondrial metabolic reprogramming-mediated immunogenic cell death reveals immune and prognostic features of clear cell renal cell carcinoma. Frontiers in Oncology. 13. 1146657–1146657. 3 indexed citations
12.
Zhu, Yanli, Sheng Li, Haiyue Wang, et al.. (2023). Molecular subtype expression and genomic profiling differ between surgically resected pure and combined small cell lung carcinoma. Human Pathology. 141. 118–129. 3 indexed citations
13.
Laroche, Fabrice, Sheng Li, Ning Shen, et al.. (2023). S1P1 Threonine 236 Phosphorylation Mediates the Invasiveness of Triple-Negative Breast Cancer and Sensitivity to FTY720. Cells. 12(7). 980–980. 6 indexed citations
14.
Tang, Shunli, Sheng Li, Shuni Ying, et al.. (2022). Underlying Systemic Diseases in Interstitial Granulomatous Dermatitis and Palisaded Neutrophilic Granulomatous Dermatitis: A Systematic Review. Dermatology. 239(2). 287–298. 4 indexed citations
15.
Li, Sheng, Lei Ruan, Zilin Chen, et al.. (2022). Engulfment and cell motility protein 1 fosters reprogramming of tumor‐associated macrophages in colorectal cancer. Cancer Science. 114(2). 410–422. 5 indexed citations
16.
Ying, Shuni, Duo Lv, Dingxian Zhu, et al.. (2022). Development and validation of the AF score for diagnosis of adult-onset Still's disease in fever of unknown origin. Journal of Translational Autoimmunity. 6. 100184–100184. 4 indexed citations
17.
Liu, Xiaoping, et al.. (2020). To construct a ceRNA regulatory network as prognostic biomarkers for bladder cancer. Journal of Cellular and Molecular Medicine. 24(9). 5375–5386. 48 indexed citations
18.
Chen, Min, Fuman Jiang, Jiayan Wang, et al.. (2019). Validation of fetal DNA fraction estimation and its application in noninvasive prenatal testing for aneuploidy detection in multiple pregnancies. Prenatal Diagnosis. 39(13). 1273–1282. 12 indexed citations
19.
Tian, Xiangge, Fei Yan, Xiaolin Cui, et al.. (2019). Endoplasmic Reticulum Targeting Ratiometric Fluorescent Probe for Carboxylesterase 2 Detection in Drug-Induced Acute Liver Injury. Analytical Chemistry. 91(24). 15840–15845. 88 indexed citations
20.
Mendillo, Marc L., Victoria V. Hargreaves, Sheng Li, et al.. (2009). A conserved MutS homolog connector domain interface interacts with MutL homologs. Proceedings of the National Academy of Sciences. 106(52). 22223–22228. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026